Mayo Clinic Laboratories offers a robust menu of biomarker testing to assess liver disease related to nonalcoholic and alcoholic causes. These include FibroTest-ActiTest, a first-line screening assay that uses two diagnostic scores based on...
Building an effective supply provision program - Insights
Having an efficient and effective supply provision program is a cornerstone for laboratory outreach program success. By providing adequate specimen collection supplies in compliance with current regulations, the outreach laboratory-customer...
Skip to Content MayoACCESS MayoLINK...
CPT codes and LOINC update: August 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of August.
Accurate Kidney Stone Analysis - Insights
In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic Laboratories’ AI-augmented kidney stone test and discusses the proper procedures for collecting and processing kidney stones to provide accurate, cost-effective analysis of...
Check out Mayo Clinic Laboratories’ biochemical and molecular testing options to diagnose creatine deficiency disorders.
newborn-screen-follow-up-elevated-c5-oh.pdf
05/2023© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Newborn Screen Follow-up for Elevated C5-OH Newborn screen result: Elevated 3-hydroxyisovaleryl- /2-methyl-3-hydroxybutyryl-carnitine...
January 2023 - Biochemical Genetics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Biochemical Genetics.
New tests launched in November - Insights
Mayo Clinic Laboratories launched the following three tests in November.
New tests launched in April - Insights
In April 2023, Mayo Clinic Laboratories announced 10 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.